Market Overview

UPDATE: Wedbush Downgrades Lennar And DR Horton To Neutral As Firm Is 'cautiously optimistic on new home demand, but we are more apt to take profits in the current environment due to affordability issues and what feels like a slow start to the spring'

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for LEN

DateFirmActionFromTo
Apr 2019SusquehannaDowngradesPositiveNeutral
Apr 2019Raymond JamesDowngradesStrong BuyOutperform
Mar 2019KeyBancMaintainsOverweightOverweight

View More Analyst Ratings for LEN
View the Latest Analyst Ratings

Posted-In: Analyst Color News Downgrades Analyst Ratings

 

Related Articles (DHI + LEN)

Latest Ratings

StockFirmActionPT
ECLUBSDowngrades186.0
WWDWilliam BlairInitiates Coverage On0.0
HMSYGuggenheimInitiates Coverage On0.0
MDSOGuggenheimInitiates Coverage On92.0
HSICGuggenheimInitiates Coverage On72.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Merck To Buy Immune Design For $300M

Spike In Miners ETF Volume Matched By Leveraged Peers